Tandem Diabetes Care, Inc. Payments for Repurchase of Initial Public Offering
Tandem Diabetes Care, Inc. (TNDM) reported Payments for Repurchase of Initial Public Offering of $635.63 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2014-11-06
- 2013-09-30: Payments for Repurchase of Initial Public Offering 9 month $635.63K.
| Period end | Payments for Repurchase of Initial Public Offering 9 month |
|---|---|
| 2013-09-30 | $635.63K 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |